Diabetes News for the Spanish Speaking Community
Original Article: https://www.medscape.com/viewarticle/ai-directed-diabetes-prevention-program-effective-human-2025a1000xam
The StudyResearchers wanted to find out if a diabetes‑prevention program run entirely by artificial intelligence (AI) could work as well as traditional programs led by human coaches. The goal was to help people with prediabetes — meaning … [Read More]
Original Article: https://www.medscape.com/viewarticle/protein-exercise-can-curb-muscle-loss-related-glp-1-ras-2025a1000yab
What the Problem isFor people using GLP‑1 receptor agonists (GLP‑1 RAs), which are medications often prescribed for weight loss or diabetes, they can lose not only fat but also significant amounts of muscle. This … [Read More]
Original Article: https://www.medscape.com/viewarticle/do-key-diabetes-risk-factors-differ-regionally-2025a1000v0k
What the Study Looked AtA recent study compared social and behavioral factors linked with diagnosed diabetes in Southern California to those observed across the entire United States. Researchers used data modeled at the level of … [Read More]
Original Article: https://www.medscape.com/viewarticle/inside-epics-rapid-fire-research-machine-2025a1000um9
How Epic Is Rethinking Medical ResearchEpic Research, a branch of the electronic health record company Epic, is using its massive Cosmos database to conduct large-scale medical research studies. Instead of relying on the traditional journal route, … [Read More]
Original Article: https://www.theguardian.com/science/2025/nov/18/root-canal-treatment-could-significantly-lower-blood-sugar-levels-study-suggests
A Surprising Health Benefit of Root CanalsTreating a common dental infection with root canal therapy may do more than save a tooth. It could also contribute to better blood sugar control, reduce inflammation, and improve cholesterol … [Read More]
Original Article: https://www.medscape.com/viewarticle/sglt2-inhibitors-promising-heart-health-seniors-2025a1000rlg
Background & Study OverviewA recent analysis looked at nine clinical trials conducted between 2015 and 2025 in older adults with cardiovascular disease, focusing on SGLT2 inhibitors (Dapagliflozin, Empagliflozin, and Sotagliflozin). The trials included nearly 25,000 … [Read More]
Original Article: https://www.medscape.com/viewarticle/continuous-glucose-monitoring-uncovers-hidden-glycemic-risks-2025a1000u40
Study Highlights & Why It MattersA recent study has shown that continuous glucose monitoring (CGM) may be a useful tool for patients undergoing dialysis for kidney disease—particularly those with diabetes—because it uncovers episodes of high … [Read More]
Original Article: https://www.medscape.com/viewarticle/artificial-intelligences-evolving-role-diabetes-care-2025a1000rik
What’s Changing in Diabetes CareArtificial intelligence (AI) is becoming a game-changer for diabetes management, helping with everything from early detection to everyday treatment decisions. Today, AI is being used to analyze large amounts of medical … [Read More]
Original Article: https://www.medscape.com/viewarticle/diabetes-linked-dementia-latest-evidence-revealed-2025a1000svk
What the Research ShowsRecent analyses reveal that people with diabetes face significantly higher risks of dementia, and in some populations, increased mortality from dementia-related causes. A large multinational study covering over 61 million people found … [Read More]
Original Article: https://www.medscape.com/s/viewarticle/walmart-be-first-us-retailer-sell-abbotts-continuous-glucose-2025a1000sj0
OverviewWalmart will become the first brick‑and‑mortar U.S. retailer to offer an over‑the‑counter continuous glucose monitor (CGM), the Lingo from Abbott Diabetes Care, in its physical stores and online.
What’s NewPreviously available only via HelloLingo.com … [Read More]
